期刊文献+

乳头状甲状腺癌VDR及OPN的表达与钙化的关系及临床意义 被引量:6

The Relationship between the VDR and OPN Expressions and Calcification in Papillary Thyroid Cancer and Clinical Significance
下载PDF
导出
摘要 通过检测甲状腺良恶性病灶中维生素D受体(vitamin D receptor,VDR)及骨桥蛋白(Osteopontin,OPN)的表达情况,探讨其在甲状腺癌钙化及发生、发展中的作用。实验组选取钙化和非钙化各30例的乳头状甲状腺癌病例共60例,对照组用良性结节性甲状腺肿15例和甲状腺腺瘤15例,通过免疫组织化学法检测良恶性甲状腺组织中VDR及OPN的表达情况,分析其在良恶性之间、乳头状甲状腺癌钙化与非钙化之间以及其他临床病理因素之间的差异及相关性。结果VDR与OPN在乳头状甲状腺癌中的表达明显高于良性病灶(P<0.01);VDR与OPN的表达与患者性别、年龄及淋巴结转移之间无统计学差异,但与乳头状甲状腺癌是否钙化及大小之间有统计学差异,并存在正相关性。肿块钙化或大于1cm的乳头状甲状腺癌VDR和OPN的表达明显增高,VDR和OPN表达亦为正相关(P<0.05)。因此,VDR和OPN蛋白增强可能参与了乳头状甲状腺癌钙化的形成以及肿瘤发生、发展的过程。 By the detection of the vitamin D receptor ( VDR) and osteopontin protein ( OPN) expressions in thyroid benign and malignant lesions, to explore its role in the calcification and occurrence and development of thyroid cancer. Select a total of 60 cases of calcified and non-calcified 30 cases of papillary thyroid cancer cases for experimental group, in the con trol group with 15 cases of benign nodular goiter and 15 cases of thyroid adenoma. VDR and OPN expressions were detec ted by immunohistochemistry in benign and malignant thyroid tissue. The difference and correlation of VDR and OPN ex pressions were analyses between benign and malignant, between the papillary thyroid cancer calcification and non--calcified, and other clinicopathological factors. VDR and OPN expressions in papillary thyroid cancer was significantly higher than benign lesions (P〈0.01). No significant difference existed between the expressions of VDR and OPN and patient gender, age and lymph node metastasis, but there were significant differences in papillary thyroid cancer whether calcifica tion and size, and there were positive correlation. VDR and OPN expressions were significantly increased in tumor calcification, or greater than lcm of papillary thyroid cancer, and VDR and OPN expressions were also positive correlation (P〈 0.05 ). VDR and OPN enhancement may be involved in the calcification of papillary thyroid carcinoma formation and cancer development process.
出处 《医学与哲学(B)》 2012年第10期64-66,74,共4页 Medicine & Philosophy(B)
基金 国家自然科学基金项目 项目编号:20972046
关键词 乳头状甲状腺癌 维生素D受体 骨桥蛋白 papillary thyroid cancer, vitamin D receptor, osteopontin
  • 相关文献

参考文献3

二级参考文献12

  • 1胡滨,罗兰,胡兵,周永昌.超声诊断甲状腺结节误诊原因分析[J].中国医学影像学杂志,2004,12(6):408-409. 被引量:23
  • 2Sherman SI. Thyroid carcinoma[J]. Lancet, 2003,361:501-511.
  • 3Cooper D S,Doherty G M, Haugen B R, et al. Manegement guidelines for petients with thyroid nodules and differentiated thyroider[J]. Thyroid, 2006,16:1 - 33.
  • 4Baloeh Z W,LiVolsi V A,Asa S L, et al. Diagnostic terminology and morphologie criteria for cytologic diagnosis of thyroid lesion: a synopsis of the National Cancer Iustitute Thyroid Fine-Needle Aspiration state of the science conference[J]. Diagn cytopathol, 2008,36: 425- 437.
  • 5Kim E,Park J S,Son K R,et al. Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma : comparison of ultrasound, computed tomography and combined ultrasound with computed tomography[J]. Thyroid,2008,18:411-418.
  • 6Mitchell J C,Grant F,Evenson A R,et al. Preoperative evaluation of thyroid nodules with 18 FDG--PET--CT[J]. Surgery, 2005,138 : 1166 - 1174.
  • 7Nix P, Nicolaides A, coatesworth A P. Thyroid cancer review: presentation and investigation of thyroid cancer[J]. Int J clin praet, 2005,59: 1459-1463.
  • 8Davies L, Welch H G. Increasing of thyroid cancer in The United States, 1973 - 2002 [J]. JAMA, 2006,295: 2164 - 2167.
  • 9向俊,吴毅.甲状腺癌临床诊治新特点(附572例临床分析)[J].中国实用外科杂志,2008,28(5):365-367. 被引量:106
  • 10吴毅.分化性甲状腺癌的外科治疗[J].外科理论与实践,2009,14(4):377-378. 被引量:18

共引文献28

同被引文献89

  • 1宋亮年.1,25-二羟维生素D_3的免疫调节作用[J].生理科学进展,1994,25(1):83-85. 被引量:18
  • 2黄爱萍.维生素D缺乏性佝偻病的免疫功能研究[J].实用儿科临床杂志,1996,11(2):67-69. 被引量:19
  • 3傅国香,朱鼎良,刘建军,高平进.骨桥蛋白参与血管紧张素Ⅱ诱导的血管平滑肌细胞迁移[J].高血压杂志,2006,14(4):277-280. 被引量:13
  • 4王栋钢,熊丰,雷培芸.维生素D_3对儿童桥本甲状腺炎T_H1/T_H2型细胞因子的影响[J].中国实用儿科杂志,2006,21(12):936-938. 被引量:11
  • 5Rot A, yon Andrian U H. Chemokines in innate and adaptive host defense:basic chemokinese grammar for immune cells[J]. Annu Rev Immunol, 2004,22 : 891 - 928.
  • 6Nix P, Nicolaides A,Coatesworth A P. Thyroid cancer review 2 :presenta- tion and investigation of thyroid cancer[J]. Int J Clin Pratt, 2005,59 ( 12 ) 1459-1463.
  • 7Balabanian K, Lagane B, Infantino S, etal. The chemo-kine SDF-1/ CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes[J]. J Biol Chem, 2005,280 (42) : 35760- 35766.
  • 8Burns J M, Summers B C, Wang Y, et aL A novel Chemokine receptor for SDF-1 and I TAC involved in cell survival, cell adhesion, and tumor development[J].J Exp Med,2006,203(9):2201 2213.
  • 9Faber A, Goessler U R, Hoermann K, et al. SDF-1 CXCR4 axis:Cell trafficking in thecancer stem cell niche of head and neck squa mouscellcareinoma[J].OneolRep,2013,29(6):2325-2331.
  • 10Liu Z,Sun D X,Teng X Y,et al. Expression of stromal cell-derived factor 1 and CXCR7 in papillary thyroid carcinoma[J]. Endocr Pathol,2012,23(4) :247-253.

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部